EMVision Medical Devices Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

EMVision Medical Devices şirketinin toplam hissedar öz sermayesi A$18.5M ve toplam borcu A$2.6M olup, bu da borç-öz sermaye oranını 14% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$24.0M ve A$5.5M dir.

Anahtar bilgiler

14.0%

Borç/özkaynak oranı

AU$2.59m

Borç

Faiz karşılama oranı	n/a
Nakit	AU$18.61m
Eşitlik	AU$18.52m
Toplam yükümlülükler	AU$5.46m
Toplam varlıklar	AU$23.97m

Son finansal sağlık güncellemeleri

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Aug 28

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Nov 21

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

Apr 24

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Oct 04

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Jun 17

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Jan 07

Recent updates

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Aug 28

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Nov 21

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

Apr 24

EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

Nov 09

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Oct 04

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Jun 17

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

Feb 22

Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

Dec 20

We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

Nov 24

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: EMV 'nin kısa vadeli varlıkları ( A$21.9M ) kısa vadeli yükümlülüklerini ( A$3.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: EMV şirketinin kısa vadeli varlıkları ( A$21.9M ) uzun vadeli yükümlülüklerini ( A$2.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: EMV şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: EMV şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 14% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: EMV şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: EMV serbest nakit akışı her yıl % 9.4 2.2 yıl yetecek nakit akışına sahip olacaktır.

EMVision Medical Devices Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Recent updates

EMVision Medical Devices Ltd, Annual General Meeting, Nov 14, 2024

EMVision Medical Devices (ASX:EMV) Is Using Debt Safely

Full year 2024 earnings released: AU$0.034 loss per share (vs AU$0.05 loss in FY 2023)

EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

EMVision Medical Devices Ltd has filed a Follow-on Equity Offering in the amount of AUD 15.281174 million.

EMVision Medical Devices Ltd has completed a Follow-on Equity Offering in the amount of AUD 15.281174 million.

EMVision Medical Devices Ltd announced that it expects to receive AUD 15.281174 million in funding from Keysight Technologies, Inc.

Is EMVision Medical Devices (ASX:EMV) A Risky Investment?

EMVision Medical Devices Ltd, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings released: AU$0.05 loss per share (vs AU$0.081 loss in FY 2022)

New minor risk - Financial data availability

Emvision Medical Devices Limited Receives $1.75 Million Manufacturing Grant Award

Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation

No longer forecast to breakeven

EMVision Medical Devices Limited Provides an Update on Its Clinical Trial and Achievement of an Important Technical Development Milestone

EMVision Commences Clinical Trial

Less than half of directors are independent

EMVision Medical Devices Ltd Announces its Portable Brain Scanner Delivered to First Clinical Site

EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment

We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate

EMVision Medical Devices Ltd, Annual General Meeting, Nov 16, 2022

Full year 2022 earnings released: AU$0.081 loss per share (vs AU$0.12 loss in FY 2021)

Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth

Less than half of directors are independent

EMvision Medical Devices Limited Announces Clinical Advisory Board Appointments

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

CEO, MD & Director exercised options to buy AU$2.3m worth of stock.

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Full year 2021 earnings released: AU$0.12 loss per share (vs AU$0.057 loss in FY 2020)

EMvision Medical Devices Limited provides an update on the build of its First Gen device

We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate

Medical Devices Limited Announces Australian Stroke Alliance in Collaboration with EMVision Wins Stage 2 MRFF Bid

Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation

New 90-day low: AU$2.70

EMvision Medical Devices Limited Announces FDA Provides De Novo Guidance

New 90-day low: AU$2.71

EMvision Medical Devices Limited Submits 513(G) Request for Information to the United States Food and Drug Administration

Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%

EMVision Medical Devices Limited Appoints Stuart Crozier as Chief Scientific Officer

We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth

New 90-day high: AU$3.01

EMvision Medical Devices Limited Announces Board Changes

New 90-day high - AU$2.35

Full year earnings released - AU$0.056 loss per share

New 90-day high - AU$1.90

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin